Achievements

Technology to film-coat core tablets with APIs

• 

  Formulation Development - Active coating

  Overview

  • Active Coating Technology is a platform that enables multiple active pharmaceutical ingredients to be incorporated into a single tablet by layering an additional coating of active ingredients onto a core tablet.

  Possessed Technologies

  • Stability enhancement technology by separating API from the core layer
  • Improved patient compliance by reducing tablet size compared to conventional combination drugs

  Distinguishing Point

  • Enhanced quality stability by physically isolating interactions between the core tablet and coating layer
  • Oral formulation technology enabling dual-release through active ingredient coating

PolyCap

• 

  PolyCap

  Overview

  • PolyCap is a complex controlled-release formulation that encapsulates multiple multilayer tablets with different release profiles into a single capsule.

  Possessed Technologies

  • Independent release design technology for each tablet
  • Multilayer tablet compression technology
  • Capsule filling and arrangement control technology for multiple tablets
  • Design technology for simultaneous or delayed release of multiple ingredients

  Distinguishing Points

  • Improved patient compliance through combination therapy in a single capsule
  • Greater formulation flexibility compared to conventional technologies

OROS

• 

  OROS

  Overview

  • OROS (Osmotic-Controlled Release Oral Delivery System) is a controlled-release solid dosage form designed to deliver drugs at a consistent rate over an extended period using osmotic pressure.

  Possessed Technologies

  • Core-shell structural design technology for osmotic control
  • Formulation optimization technology based on drug release profile simulation
  • Multi-layer structure design technology for combination and multi-release formulations

  Distinguishing Point

  • Oral formulation technology that improves patient adherence through sustained release
  • Capability to maximize therapeutic effects by minimizing fluctuations in plasma drug concentration